Vanadium toxicity: Difference between revisions
Ostermayer (talk | contribs) (Created page with "Vanadium toxicity is a rare poisoning caused by exposure to vanadium compounds, most commonly through occupational inhalation of vanadium pentoxide (V₂O₅) dust or, far less commonly, through ingestion of vanadium salts. Inhalation toxicity primarily manifests as respiratory irritation and occupational asthma ('''"boilermaker's bronchitis"'''), while ingestion of large amounts can cause acute multiorgan failure and death.<ref name="ATSDR2012">Agency for Toxic Substanc...") |
(Strip excess bold) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Vanadium toxicity is a rare poisoning caused by exposure to vanadium compounds, most commonly through occupational inhalation of vanadium pentoxide (V₂O₅) dust or, far less commonly, through ingestion of vanadium salts. | |||
*Inhalation toxicity primarily manifests as respiratory irritation and occupational asthma ('''"boilermaker's bronchitis"'''), while ingestion of large amounts can cause acute multiorgan failure and death.<ref name="ATSDR2012">Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Vanadium. U.S. Department of Health and Human Services. 2012.</ref> | |||
*Vanadium (V) is a transition metal found ubiquitously in the environment in mineral ores and fossil fuels | *Vanadium (V) is a transition metal found ubiquitously in the environment in mineral ores and fossil fuels | ||
*Common oxidation states: V³⁺, V⁴⁺ (vanadyl), V⁵⁺ (vanadate) — '''pentavalent (V⁵⁺) compounds are the most toxic'''<ref name="ATSDR2012"/> | *Common oxidation states: V³⁺, V⁴⁺ (vanadyl), V⁵⁺ (vanadate) — '''pentavalent (V⁵⁺) compounds are the most toxic'''<ref name="ATSDR2012"/> | ||
*Toxicologically significant compounds: | *Toxicologically significant compounds: | ||
** | ** Vanadium pentoxide (V₂O₅) — most common occupational exposure (dust/fume) | ||
** | ** Ammonium metavanadate (NH₄VO₃) — used in laboratory and industrial settings | ||
** | ** Sodium metavanadate (NaVO₃) and sodium orthovanadate (Na₃VO₄) | ||
** | ** Vanadyl sulfate (VOSO₄) — sold as a dietary/bodybuilding supplement | ||
*Sources of exposure: | *Sources of exposure: | ||
** | ** Occupational: boiler cleaning (oil-fired), vanadium refining, steel/alloy manufacturing, fossil fuel combustion, catalyst production<ref name="Musk1982">Musk AW, Tees JG. Asthma caused by occupational exposure to vanadium compounds. ''Med J Aust''. 1982;1(4):183-184.</ref> | ||
** | ** Dietary supplements: vanadyl sulfate used by athletes/bodybuilders for purported anabolic and insulin-mimetic effects (doses up to 60 mg/day)<ref name="ATSDR2012"/> | ||
** | ** Environmental: air pollution near power plants; contaminated groundwater (rare) | ||
** | ** Intentional: extremely rare; only two fatal ingestion cases in the world literature<ref name="Boulassel2011">Boulassel B, et al. Fatal poisoning by vanadium. ''Forensic Sci Int''. 2011;206(1-3):e79-81. doi:10.1016/j.forsciint.2010.08.021</ref> | ||
*Vanadium pentoxide is | *Vanadium pentoxide is ~100% absorbed by inhalation but only 0.1-1% absorbed orally<ref name="ATSDR2012"/> | ||
*60% of absorbed vanadium is excreted renally within 24 hours | *60% of absorbed vanadium is excreted renally within 24 hours | ||
*Vanadium has insulin-mimetic properties and has been studied as a diabetes treatment; GI side effects are dose-limiting | *Vanadium has insulin-mimetic properties and has been studied as a diabetes treatment; GI side effects are dose-limiting | ||
===Mechanism of toxicity=== | ===Mechanism of toxicity=== | ||
*Generates | *Generates reactive oxygen species (ROS) → lipid peroxidation, glutathione depletion, oxidative stress<ref name="Zwolak2020">Zwolak I. Protective effects of dietary antioxidants against vanadium-induced toxicity: a review. ''Oxid Med Cell Longev''. 2020;2020:1490316. doi:10.1155/2020/1490316</ref> | ||
*Inhibits | *Inhibits Na⁺/K⁺-ATPase, phosphotyrosine phosphatases, ribonuclease, and other enzymes | ||
*In massive ingestion, may inhibit | *In massive ingestion, may inhibit cellular respiratory processes similar to other mitochondrial poisons<ref name="Boulassel2011"/> | ||
* | * Direct mucosal irritant to respiratory and GI epithelium | ||
*Pentavalent vanadium (vanadate) is reduced intracellularly to tetravalent vanadyl, with redox cycling generating additional free radicals | *Pentavalent vanadium (vanadate) is reduced intracellularly to tetravalent vanadyl, with redox cycling generating additional free radicals | ||
==Clinical features== | ==Clinical features== | ||
===Inhalation exposure (most common)=== | ===Inhalation exposure (most common)=== | ||
* | *"Boilermaker's bronchitis" — the classic occupational syndrome<ref name="Musk1982"/> | ||
* | * Upper airway: | ||
**Rhinitis, nasal congestion, epistaxis | **Rhinitis, nasal congestion, epistaxis | ||
**Pharyngitis, sore throat | **Pharyngitis, sore throat | ||
**Nasal mucosal ulceration (chronic exposure) | **Nasal mucosal ulceration (chronic exposure) | ||
* | * Lower airway: | ||
**Cough, wheezing, chest tightness, dyspnea | **Cough, wheezing, chest tightness, dyspnea | ||
**Bronchospasm, occupational asthma | **Bronchospasm, occupational asthma | ||
| Line 38: | Line 38: | ||
**Decreased FEV₁ | **Decreased FEV₁ | ||
**Chemical bronchopneumopathy (severe/massive exposure) | **Chemical bronchopneumopathy (severe/massive exposure) | ||
* | * Characteristic finding: "green tongue" — greenish discoloration of the tongue from local vanadium deposition; indicates significant dust exposure but is not a sign of systemic poisoning<ref name="HazMap">Vanadium pentoxide. Haz-Map. National Library of Medicine. 2019.</ref> | ||
* | * Systemic symptoms with heavy inhalation exposure: | ||
**Metallic taste | **Metallic taste | ||
**Headache, fatigue, tremor | **Headache, fatigue, tremor | ||
| Line 45: | Line 45: | ||
===Oral ingestion (rare)=== | ===Oral ingestion (rare)=== | ||
* | * Low-dose (supplements, <14 mg): generally well tolerated; possible mild GI irritation | ||
* | * Moderate dose (≥14 mg): nausea, vomiting, abdominal cramps, diarrhea<ref name="ATSDR2012"/> | ||
**Most patients develop tolerance to GI effects with continued exposure | **Most patients develop tolerance to GI effects with continued exposure | ||
* | * Massive ingestion (grams): extremely rare; reported features include:<ref name="Boulassel2011"/> | ||
**Severe GI symptoms (nausea, vomiting, profuse diarrhea, abdominal pain) | **Severe GI symptoms (nausea, vomiting, profuse diarrhea, abdominal pain) | ||
** | ** Hypoglycemia (insulin-mimetic effects; glucose 0.2 g/L reported in fatal case) | ||
** | ** Acute kidney injury | ||
**Respiratory distress (widespread tissue asphyxia) | **Respiratory distress (widespread tissue asphyxia) | ||
**Multiorgan failure and death | **Multiorgan failure and death | ||
| Line 64: | Line 64: | ||
*Persistent cough, wheezing, bronchial hyperreactivity | *Persistent cough, wheezing, bronchial hyperreactivity | ||
*Possible bronchitis and asthma | *Possible bronchitis and asthma | ||
* | * Hematologic: microcytic erythrocytosis has been observed in animal studies (decreased hematocrit, hemoglobin, MCV)<ref name="ATSDR2012"/> | ||
*No confirmed increased cancer risk in humans from occupational exposure; IARC has not classified vanadium | *No confirmed increased cancer risk in humans from occupational exposure; IARC has not classified vanadium | ||
| Line 75: | Line 75: | ||
*[[Hypoglycemia]] (other causes) | *[[Hypoglycemia]] (other causes) | ||
*[[Acute gastroenteritis]] | *[[Acute gastroenteritis]] | ||
{{Toxic gas exposure DDX}} | |||
==Evaluation== | ==Evaluation== | ||
===Workup=== | ===Workup=== | ||
* | * Detailed occupational and exposure history — most critical step; identify compound, route, duration, concentration | ||
* | * Pulmonary function testing: spirometry (FEV₁, FVC) — for inhalation exposure; may show obstructive pattern | ||
* | * Chest radiograph: generally normal in occupational exposure; may show infiltrates in massive inhalation | ||
* | * Labs (for significant oral ingestion): | ||
**BMP (renal function, electrolytes, | **BMP (renal function, electrolytes, blood glucose — monitor for hypoglycemia) | ||
**Hepatic function panel | **Hepatic function panel | ||
**CBC (anemia, reticulocyte count) | **CBC (anemia, reticulocyte count) | ||
**Lactate, ABG | **Lactate, ABG | ||
**Urinalysis (proteinuria, hematuria) | **Urinalysis (proteinuria, hematuria) | ||
* | * Vanadium levels: | ||
** | ** 24-hour urine vanadium — best marker of recent exposure; ACGIH Biological Exposure Index is 50 μg/g creatinine at end of shift<ref name="ATSDR2012"/> | ||
**Serum vanadium — elevated acutely (normal: ~1 μg/L; fatal case: 6,220 μg/L)<ref name="Boulassel2011"/> | **Serum vanadium — elevated acutely (normal: ~1 μg/L; fatal case: 6,220 μg/L)<ref name="Boulassel2011"/> | ||
**Hair/nail analysis for chronic exposure assessment | **Hair/nail analysis for chronic exposure assessment | ||
**Note: seafood does | **Note: seafood does not significantly elevate vanadium levels (unlike arsenic) | ||
* | * ECG: in massive ingestion (monitor for metabolic effects) | ||
===Diagnosis=== | ===Diagnosis=== | ||
* | * Inhalation: clinical diagnosis based on occupational history + respiratory symptoms + green tongue | ||
* | * Ingestion: clinical diagnosis based on history + GI symptoms + characteristic metabolic findings (hypoglycemia, renal failure); confirmed by elevated urine or serum vanadium levels | ||
*Green tongue is pathognomonic for vanadium dust exposure but does not indicate systemic poisoning<ref name="HazMap"/> | *Green tongue is pathognomonic for vanadium dust exposure but does not indicate systemic poisoning<ref name="HazMap"/> | ||
==Management== | ==Management== | ||
===Inhalation exposure=== | ===Inhalation exposure=== | ||
* | * Remove from exposure — move patient to fresh air immediately | ||
* | * Decontamination: remove contaminated clothing; wash skin with soap and water; irrigate eyes with copious water if exposed | ||
* | * Bronchospasm: inhaled beta-2 agonists ([[Albuterol|albuterol]]); systemic corticosteroids if severe | ||
* | * Supplemental oxygen as needed | ||
* | * Supportive care: most cases of occupational inhalation resolve with removal from exposure and bronchodilators | ||
*Monitor pulmonary function; bronchial hyperreactivity may persist for weeks<ref name="Musk1982"/> | *Monitor pulmonary function; bronchial hyperreactivity may persist for weeks<ref name="Musk1982"/> | ||
===Oral ingestion=== | ===Oral ingestion=== | ||
* | * GI decontamination: | ||
**Gastric lavage if presenting early after large ingestion | **Gastric lavage if presenting early after large ingestion | ||
**Activated charcoal — no specific data for vanadium, but may be considered if presenting within 1-2 hours | **Activated charcoal — no specific data for vanadium, but may be considered if presenting within 1-2 hours | ||
**Whole-bowel irrigation may be considered for large ingestions | **Whole-bowel irrigation may be considered for large ingestions | ||
* | * Aggressive IV fluid resuscitation | ||
* | * Monitor and correct blood glucose — hypoglycemia may be severe (insulin-mimetic effect); treat with IV dextrose<ref name="Boulassel2011"/> | ||
* | * Supportive care for renal failure, respiratory failure, metabolic derangements | ||
* | * Hemodialysis — may be indicated for acute kidney injury; vanadium clearance by dialysis is uncertain | ||
===Chelation therapy=== | ===Chelation therapy=== | ||
* | * No chelation therapy has proven clinical efficacy in human vanadium poisoning<ref name="Zwolak2020"/> | ||
*Agents studied (primarily in animal models): | *Agents studied (primarily in animal models): | ||
** | ** Ascorbic acid (vitamin C): most promising agent; reduces pentavalent vanadate to less toxic tetravalent vanadyl; also functions as an antioxidant and ROS scavenger; ''suggested as the safest and most effective pharmacologic option''<ref name="Zwolak2020"/> | ||
** | ** CaNa₂EDTA: enhances urinary vanadium excretion in animals; carries risk of nephrotoxicity | ||
** | ** Tiron (4,5-dihydroxybenzene-1,3-disulfonate): partially effective in animal studies | ||
** | ** DMSA, DMPS: potential chelating antidotes; limited data | ||
** | ** Deferoxamine (DFOA): limited efficacy | ||
*In practice, | *In practice, ascorbic acid (high-dose IV vitamin C) is the most reasonable adjunctive therapy based on available evidence, though it has not been validated in human clinical trials | ||
===Antioxidant therapy=== | ===Antioxidant therapy=== | ||
* | * Vitamin C: high-dose (1-2 g IV); both chelating and antioxidant properties<ref name="Zwolak2020"/> | ||
* | * Vitamin E: adjunctive antioxidant (limited evidence) | ||
*Rationale: vanadium toxicity is heavily mediated by oxidative stress; antioxidants may mitigate cellular injury | *Rationale: vanadium toxicity is heavily mediated by oxidative stress; antioxidants may mitigate cellular injury | ||
==Disposition== | ==Disposition== | ||
* | * Mild inhalation exposure (respiratory symptoms only, stable): | ||
**Observe in ED for 4-6 hours after removal from exposure | **Observe in ED for 4-6 hours after removal from exposure | ||
**Discharge if symptoms improving and pulmonary function acceptable | **Discharge if symptoms improving and pulmonary function acceptable | ||
**Occupational medicine follow-up; workplace exposure assessment | **Occupational medicine follow-up; workplace exposure assessment | ||
**Return precautions for worsening respiratory symptoms (may be delayed hours to days) | **Return precautions for worsening respiratory symptoms (may be delayed hours to days) | ||
* | * Significant inhalation exposure (severe bronchospasm, respiratory distress): | ||
**Admit for observation and treatment; monitor pulmonary function | **Admit for observation and treatment; monitor pulmonary function | ||
* | * Oral ingestion of small supplement dose: | ||
**Observe; symptomatic management of GI complaints; discharge if stable | **Observe; symptomatic management of GI complaints; discharge if stable | ||
* | * Massive oral ingestion: | ||
**ICU admission — continuous monitoring | **ICU admission — continuous monitoring | ||
**Serial glucose, renal function, ABGs | **Serial glucose, renal function, ABGs | ||
**Anticipate rapid deterioration after ~12-hour latency period<ref name="Boulassel2011"/> | **Anticipate rapid deterioration after ~12-hour latency period<ref name="Boulassel2011"/> | ||
**High mortality in the rare case of massive salt ingestion | **High mortality in the rare case of massive salt ingestion | ||
* | * All intentional ingestions: psychiatric evaluation mandatory prior to discharge | ||
*Contact [[Poison control]] (1-800-222-1222 in the US) for all cases | *Contact [[Poison control]] (1-800-222-1222 in the US) for all cases | ||
Latest revision as of 09:30, 22 March 2026
Background
- Vanadium toxicity is a rare poisoning caused by exposure to vanadium compounds, most commonly through occupational inhalation of vanadium pentoxide (V₂O₅) dust or, far less commonly, through ingestion of vanadium salts.
- Inhalation toxicity primarily manifests as respiratory irritation and occupational asthma ("boilermaker's bronchitis"), while ingestion of large amounts can cause acute multiorgan failure and death.[1]
- Vanadium (V) is a transition metal found ubiquitously in the environment in mineral ores and fossil fuels
- Common oxidation states: V³⁺, V⁴⁺ (vanadyl), V⁵⁺ (vanadate) — pentavalent (V⁵⁺) compounds are the most toxic[1]
- Toxicologically significant compounds:
- Vanadium pentoxide (V₂O₅) — most common occupational exposure (dust/fume)
- Ammonium metavanadate (NH₄VO₃) — used in laboratory and industrial settings
- Sodium metavanadate (NaVO₃) and sodium orthovanadate (Na₃VO₄)
- Vanadyl sulfate (VOSO₄) — sold as a dietary/bodybuilding supplement
- Sources of exposure:
- Occupational: boiler cleaning (oil-fired), vanadium refining, steel/alloy manufacturing, fossil fuel combustion, catalyst production[2]
- Dietary supplements: vanadyl sulfate used by athletes/bodybuilders for purported anabolic and insulin-mimetic effects (doses up to 60 mg/day)[1]
- Environmental: air pollution near power plants; contaminated groundwater (rare)
- Intentional: extremely rare; only two fatal ingestion cases in the world literature[3]
- Vanadium pentoxide is ~100% absorbed by inhalation but only 0.1-1% absorbed orally[1]
- 60% of absorbed vanadium is excreted renally within 24 hours
- Vanadium has insulin-mimetic properties and has been studied as a diabetes treatment; GI side effects are dose-limiting
Mechanism of toxicity
- Generates reactive oxygen species (ROS) → lipid peroxidation, glutathione depletion, oxidative stress[4]
- Inhibits Na⁺/K⁺-ATPase, phosphotyrosine phosphatases, ribonuclease, and other enzymes
- In massive ingestion, may inhibit cellular respiratory processes similar to other mitochondrial poisons[3]
- Direct mucosal irritant to respiratory and GI epithelium
- Pentavalent vanadium (vanadate) is reduced intracellularly to tetravalent vanadyl, with redox cycling generating additional free radicals
Clinical features
Inhalation exposure (most common)
- "Boilermaker's bronchitis" — the classic occupational syndrome[2]
- Upper airway:
- Rhinitis, nasal congestion, epistaxis
- Pharyngitis, sore throat
- Nasal mucosal ulceration (chronic exposure)
- Lower airway:
- Cough, wheezing, chest tightness, dyspnea
- Bronchospasm, occupational asthma
- Bronchial hyperreactivity (may persist weeks after exposure)[2]
- Decreased FEV₁
- Chemical bronchopneumopathy (severe/massive exposure)
- Characteristic finding: "green tongue" — greenish discoloration of the tongue from local vanadium deposition; indicates significant dust exposure but is not a sign of systemic poisoning[5]
- Systemic symptoms with heavy inhalation exposure:
- Metallic taste
- Headache, fatigue, tremor
- Conjunctivitis, lacrimation
Oral ingestion (rare)
- Low-dose (supplements, <14 mg): generally well tolerated; possible mild GI irritation
- Moderate dose (≥14 mg): nausea, vomiting, abdominal cramps, diarrhea[1]
- Most patients develop tolerance to GI effects with continued exposure
- Massive ingestion (grams): extremely rare; reported features include:[3]
- Severe GI symptoms (nausea, vomiting, profuse diarrhea, abdominal pain)
- Hypoglycemia (insulin-mimetic effects; glucose 0.2 g/L reported in fatal case)
- Acute kidney injury
- Respiratory distress (widespread tissue asphyxia)
- Multiorgan failure and death
- Symptom latency of approximately 12 hours before rapid clinical deterioration
Dermal/ocular exposure
- Concentrated vanadium chloride or oxide solutions cause chemical burns
- Eye contact with vanadium pentoxide dust causes conjunctivitis, corneal irritation
- Skin sensitization is extremely rare[1]
Chronic exposure
- Persistent cough, wheezing, bronchial hyperreactivity
- Possible bronchitis and asthma
- Hematologic: microcytic erythrocytosis has been observed in animal studies (decreased hematocrit, hemoglobin, MCV)[1]
- No confirmed increased cancer risk in humans from occupational exposure; IARC has not classified vanadium
Differential diagnosis
Acute ingestion
- Iron toxicity (similar GI + metabolic acidosis picture)
- Arsenic poisoning (similar GI onset)
- Caustic ingestion
- Hypoglycemia (other causes)
- Acute gastroenteritis
Toxic gas exposure
- Carbon monoxide toxicity
- Chemical weapons
- Cyanide toxicity
- Dichloromethane toxicity
- Hydrocarbon toxicity
- Hydrogen sulfide toxicity
- Inhalant abuse
- Methane toxicity
- Smoke inhalation injury
- Ethylene dibromide toxicity
Evaluation
Workup
- Detailed occupational and exposure history — most critical step; identify compound, route, duration, concentration
- Pulmonary function testing: spirometry (FEV₁, FVC) — for inhalation exposure; may show obstructive pattern
- Chest radiograph: generally normal in occupational exposure; may show infiltrates in massive inhalation
- Labs (for significant oral ingestion):
- BMP (renal function, electrolytes, blood glucose — monitor for hypoglycemia)
- Hepatic function panel
- CBC (anemia, reticulocyte count)
- Lactate, ABG
- Urinalysis (proteinuria, hematuria)
- Vanadium levels:
- 24-hour urine vanadium — best marker of recent exposure; ACGIH Biological Exposure Index is 50 μg/g creatinine at end of shift[1]
- Serum vanadium — elevated acutely (normal: ~1 μg/L; fatal case: 6,220 μg/L)[3]
- Hair/nail analysis for chronic exposure assessment
- Note: seafood does not significantly elevate vanadium levels (unlike arsenic)
- ECG: in massive ingestion (monitor for metabolic effects)
Diagnosis
- Inhalation: clinical diagnosis based on occupational history + respiratory symptoms + green tongue
- Ingestion: clinical diagnosis based on history + GI symptoms + characteristic metabolic findings (hypoglycemia, renal failure); confirmed by elevated urine or serum vanadium levels
- Green tongue is pathognomonic for vanadium dust exposure but does not indicate systemic poisoning[5]
Management
Inhalation exposure
- Remove from exposure — move patient to fresh air immediately
- Decontamination: remove contaminated clothing; wash skin with soap and water; irrigate eyes with copious water if exposed
- Bronchospasm: inhaled beta-2 agonists (albuterol); systemic corticosteroids if severe
- Supplemental oxygen as needed
- Supportive care: most cases of occupational inhalation resolve with removal from exposure and bronchodilators
- Monitor pulmonary function; bronchial hyperreactivity may persist for weeks[2]
Oral ingestion
- GI decontamination:
- Gastric lavage if presenting early after large ingestion
- Activated charcoal — no specific data for vanadium, but may be considered if presenting within 1-2 hours
- Whole-bowel irrigation may be considered for large ingestions
- Aggressive IV fluid resuscitation
- Monitor and correct blood glucose — hypoglycemia may be severe (insulin-mimetic effect); treat with IV dextrose[3]
- Supportive care for renal failure, respiratory failure, metabolic derangements
- Hemodialysis — may be indicated for acute kidney injury; vanadium clearance by dialysis is uncertain
Chelation therapy
- No chelation therapy has proven clinical efficacy in human vanadium poisoning[4]
- Agents studied (primarily in animal models):
- Ascorbic acid (vitamin C): most promising agent; reduces pentavalent vanadate to less toxic tetravalent vanadyl; also functions as an antioxidant and ROS scavenger; suggested as the safest and most effective pharmacologic option[4]
- CaNa₂EDTA: enhances urinary vanadium excretion in animals; carries risk of nephrotoxicity
- Tiron (4,5-dihydroxybenzene-1,3-disulfonate): partially effective in animal studies
- DMSA, DMPS: potential chelating antidotes; limited data
- Deferoxamine (DFOA): limited efficacy
- In practice, ascorbic acid (high-dose IV vitamin C) is the most reasonable adjunctive therapy based on available evidence, though it has not been validated in human clinical trials
Antioxidant therapy
- Vitamin C: high-dose (1-2 g IV); both chelating and antioxidant properties[4]
- Vitamin E: adjunctive antioxidant (limited evidence)
- Rationale: vanadium toxicity is heavily mediated by oxidative stress; antioxidants may mitigate cellular injury
Disposition
- Mild inhalation exposure (respiratory symptoms only, stable):
- Observe in ED for 4-6 hours after removal from exposure
- Discharge if symptoms improving and pulmonary function acceptable
- Occupational medicine follow-up; workplace exposure assessment
- Return precautions for worsening respiratory symptoms (may be delayed hours to days)
- Significant inhalation exposure (severe bronchospasm, respiratory distress):
- Admit for observation and treatment; monitor pulmonary function
- Oral ingestion of small supplement dose:
- Observe; symptomatic management of GI complaints; discharge if stable
- Massive oral ingestion:
- ICU admission — continuous monitoring
- Serial glucose, renal function, ABGs
- Anticipate rapid deterioration after ~12-hour latency period[3]
- High mortality in the rare case of massive salt ingestion
- All intentional ingestions: psychiatric evaluation mandatory prior to discharge
- Contact Poison control (1-800-222-1222 in the US) for all cases
See Also
External Links
- ATSDR — Toxicological Profile for Vanadium: Health Effects (2012)
- Oxid Med Cell Longev — Protective Effects of Dietary Antioxidants against Vanadium-Induced Toxicity (2020)
- ATSDR — Vanadium Medical Management Guidelines
- Haz-Map — Vanadium Pentoxide
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Vanadium. U.S. Department of Health and Human Services. 2012.
- ↑ 2.0 2.1 2.2 2.3 Musk AW, Tees JG. Asthma caused by occupational exposure to vanadium compounds. Med J Aust. 1982;1(4):183-184.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Boulassel B, et al. Fatal poisoning by vanadium. Forensic Sci Int. 2011;206(1-3):e79-81. doi:10.1016/j.forsciint.2010.08.021
- ↑ 4.0 4.1 4.2 4.3 Zwolak I. Protective effects of dietary antioxidants against vanadium-induced toxicity: a review. Oxid Med Cell Longev. 2020;2020:1490316. doi:10.1155/2020/1490316
- ↑ 5.0 5.1 Vanadium pentoxide. Haz-Map. National Library of Medicine. 2019.
